Home Jacobio

Jacobio

In operation
Post-IPO Round
Innovative Drug Developer

Basic Information

Jacobio is an innovative drug developer dedicated to the research and development of two projects: malignant tumors and sepsis. It has departments such as the synthesis lab, analysis lab, formulation lab, pharmacology department, QA lab, registration office, and medical department, providing users with products like novel antibody drugs and the small-molecule oral anti-tumor drug JAB-3068.
Beijing Jiakesi New Drug Development Co., Ltd.
Beijing,China
101~500 people
July 17, 2015
yuncong.zhang@jacobiopharma.com